Loading...
XHKG
2005
Market cap1.18bUSD
Dec 05, Last price  
3.10HKD
1D
0.00%
1Q
-4.62%
Jan 2017
25.51%
IPO
629.41%
Name

SSY Group Ltd

Chart & Performance

D1W1MN
XHKG:2005 chart
P/E
8.63
P/S
1.59
EPS
0.36
Div Yield, %
5.81%
Shrs. gr., 5y
-0.58%
Rev. gr., 5y
4.49%
Revenues
5.77b
-10.67%
849,916,765858,323,1461,180,455,3481,591,028,0001,739,628,0001,971,657,0002,155,215,0002,430,684,0002,745,316,0002,091,471,0002,221,921,0002,361,250,0003,076,369,0004,180,787,9994,635,675,0004,260,898,0005,356,763,0006,434,025,0006,463,009,0005,773,251,000
Net income
1.06b
-19.53%
111,962,68993,115,546123,833,773102,106,000216,095,000260,592,000-41,401,000281,003,000411,814,000602,929,000403,416,000489,535,000664,719,000911,774,0001,136,101,000611,971,000785,533,0001,122,837,0001,318,616,0001,061,150,000
CFO
491m
-46.96%
136,783,61925,180,00289,490,122142,685,000228,241,000287,807,000171,498,000242,068,000597,922,000307,607,000562,694,000686,484,000552,438,000969,825,000669,355,000527,644,000747,906,000786,824,000925,747,000491,031,000
Dividend
Sep 12, 20240.08 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.
URL
http://www.ssygroup.com.hk/
IPO date
Dec 20, 2005
Employees
5,300
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT